While transgene and sh‐CTRL expression had no impact on PDX proliferation in vivo (Fig EV3B), silencing XIAP induced a clear growth disadvantage in the absence of chemotherapy in both ALL‐265 and ALL‐199 (Figs 5C and EV3C). The gene discussed is XIAP; the disease is acute lymphoblastic leukemia.